Skip to main content

Table 2 Summary of all cell counts recorded

From: Mycophenolic acid counteracts B cell proliferation and plasmablast formation in patients with systemic lupus erythematosus

  AZA MMF No IS
Hemoglobin, mmol/l 7.9 (5.5-10.4) 8.2 (5.4-10.7) 8.2 (4.5-10.7)
Platelets/µl 238 (48-459) 252 (136-404) 223 (96-379)
Leukocytes 4855 (2,060-10,160) 5970 (2,640-15,550) 5225 (2,080-9,050)
Lymphocytes/µl 987 (200-3,790) 1080 (360-3,010) 1330 (300-2,910)
B cells % 4.5 (0.6-31.3)* §§§ 9.4 (0.6-40.1)* 11.8 (3.6-28.9)§§§
B cells/µl 44(3-662)** §§§ 113(4-462)** 119 (40-460)§§§
T % of L 76 (28-93)* 63 (24-85)* 64 (42,2-84,5)
T/µl 584 (180-3,286) 640 (89-2,468) 807 (162-2,104)
CD4+ % 73 (39-82) 71 (41-92) 69 (33-92)
CD4+/µl 430 (85-1,709) 466 (61-2,021) 518 (106-1,514)
CD8+ % 19 (7-46) 22 (3-48) 22 (2-60)
CD8+/µl 127 (25-1,410) 144 (12-696) 207 (19-604)
CD4-/CD8- % 6 (2-18) 6 (2-11) 5 (2-20)
CD4-/CD8- /µl 41 (8-136) 41 (2-139) 46 (4-137)
  1. Results are presented as median (range). Statistically significant differences detected between cell counts of patients taking azathioprine (AZA) and mycophenolate mofetil (MMF) (*P < 0.05, **P < 0.01, ***P < 0.001) and AZA compared to patients not taking immunosuppressive therapy §P < 0.05, §§P < 0.01, §§§P < 0.001 (Dunn's multiple comparison test).